Abstract
In 2006, the combined U.S. market for dental bone graft substitutes and other
biomaterials was valued at slightly over $150 million. This market includes
bone graft substitutes, tissue engineering products, and dental membranes. The
market is expected to grow rapidly as the number of bone graft procedures
associated with dental implants rises. Market growth will slow down over time,
but by 2013, it will reach a value of just over $415 million.
View Cart
